Abstract |
A recombinant antibody- lymphotoxin-alpha fusion protein induced an adaptive immune response protecting mice from melanoma. Importantly, this fusion protein elicited the formation of a lymphoid-like tissue in the tumor microenvironment containing L-selectin+ T cells and MHC class II+ antigen-presenting cells, as well as B and T cell aggregates. Furthermore, PNAd+/TCA4+ high endothelial venules were observed within the tumor, suggesting entry channels for naive T cell infiltrates. Over the course of therapy, a marked clonal expansion of certain TCR specificities occurred among tumor-infiltrating lymphocytes that displayed reactivity against melanoma cells and the TRP-2(180-188) peptide. Consequently, naive T cells may have been recruited to as well as primed and expanded in the lymphoid-like tissue induced by the lymphotoxin-alpha fusion protein at the tumor site.
|
Authors | D Schrama, P thor Straten, W H Fischer, A D McLellan, E B Bröcker, R A Reisfeld, J C Becker |
Journal | Immunity
(Immunity)
Vol. 14
Issue 2
Pg. 111-21
(Feb 2001)
ISSN: 1074-7613 [Print] United States |
PMID | 11239444
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Monoclonal
- Immunotoxins
- Lymphotoxin-alpha
- Recombinant Fusion Proteins
|
Topics |
- Animals
- Antibodies, Monoclonal
(therapeutic use)
- Endothelium, Lymphatic
(immunology, pathology)
- Humans
- Immunotoxins
(therapeutic use)
- Lung Neoplasms
(immunology, secondary, therapy)
- Lymphocytes, Tumor-Infiltrating
(immunology, pathology)
- Lymphoid Tissue
(immunology, pathology)
- Lymphotoxin-alpha
(therapeutic use)
- Melanoma, Experimental
(immunology, pathology, therapy)
- Mice
- Mice, Inbred C57BL
- Microscopy, Electron
- Neoplasm Transplantation
- Neoplasms, Connective Tissue
(immunology, pathology, therapy)
- Recombinant Fusion Proteins
(therapeutic use)
- T-Lymphocytes
(immunology, pathology)
- Transplantation, Isogeneic
|